Ignite Creation Date:
2024-05-05 @ 4:51 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00326885
Status:
COMPLETED
Last Update Posted:
2018-10-17
First Post:
2006-05-15
Brief Title:
Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites
Sponsor:
Organization:
Neovii Biotech